Metastases Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Metastases stocks.

Metastases Stocks Recent News

Date Stock Title
Jul 5 AMGN What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients
Jul 5 AMGN EAN 2024: The role of B cells in shaping rituximab use in generalised MG
Jul 5 AMGN Amgen: An Emerging GLP-1 Play, Modest Mid-Teens P/E With Strong Momentum
Jul 4 AMGN NVO, LLY Slip After Study Links Obesity Drug Use to Vision Loss
Jul 4 AMGN Amgen Inc. (NASDAQ:AMGN) Shares Could Be 42% Below Their Intrinsic Value Estimate
Jul 4 AMGN Forget Eli Lilly: 3 Biotech Stocks to Buy Instead
Jul 3 AMGN S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
Jul 3 AMGN Health Care Stocks With A Long History Of Dividend Growth And Solid Yields
Jul 3 VCYT Market Sentiment Around Loss-Making Veracyte, Inc. (NASDAQ:VCYT)
Jul 2 AMGN Dow Jones Falls Amid Powell Speech; Tesla Stock Surges On Deliveries
Jul 2 YMAB MSC Industrial Direct, Radius Recycling And 3 Stocks To Watch Heading Into Tuesday
Jul 1 CADL Candel Therapeutics: Innovative Cancer Therapies, But Short Cash Runway
Jul 1 YMAB Y-mAbs names Peter Pfreundschuh as CFO
Jul 1 YMAB Y-mAbs Appoints Seasoned Biopharma Executive Peter Pfreundschuh as Chief Financial Officer
Jul 1 NVCR Novocure to Report Second Quarter 2024 Financial Results
Jul 1 AMGN Dow Jones Rallies After Economic Data; Nvidia Gets Price Target Hike
Jul 1 AMGN 10 clinical trials to watch in the second half of 2024
Jun 29 AMGN How Do These 3 Healthcare Dividend Stocks Deliver Reliable Income And Growth?
Metastases

Metastasis is a pathogenic agent's spread from an initial or primary site to a different or secondary site within the host's body; the term is typically used when referring to metastasis by a cancerous tumor. The newly pathological sites, then, are metastases (mets). It is generally distinguished from cancer invasion, which is the direct extension and penetration by cancer cells into neighboring tissues.Cancer occurs after cells are genetically altered to proliferate rapidly and indefinitely. This uncontrolled proliferation by mitosis produces a primary heterogeneic tumour. The cells which constitute the tumor eventually undergo metaplasia, followed by dysplasia then anaplasia, resulting in a malignant phenotype. This malignancy allows for invasion into the circulation, followed by invasion to a second site for tumorigenesis.
Some cancer cells known as circulating tumor cells acquire the ability to penetrate the walls of lymphatic or blood vessels, after which they are able to circulate through the bloodstream to other sites and tissues in the body. This process is known (respectively) as lymphatic or hematogenous spread. After the tumor cells come to rest at another site, they re-penetrate the vessel or walls and continue to multiply, eventually forming another clinically detectable tumor. This new tumor is known as a metastatic (or secondary) tumor. Metastasis is one of the hallmarks of cancer, distinguishing it from benign tumors. Most cancers can metastasize, although in varying degrees. Basal cell carcinoma for example rarely metastasizes.When tumor cells metastasize, the new tumor is called a secondary or metastatic tumor, and its cells are similar to those in the original or primary tumor. This means that if breast cancer metastasizes to the lungs, the secondary tumor is made up of abnormal breast cells, not of abnormal lung cells. The tumor in the lung is then called metastatic breast cancer, not lung cancer. Metastasis is a key element in cancer staging systems such as the TNM staging system, where it represents the "M". In overall stage grouping, metastasis places a cancer in Stage IV. The possibilities of curative treatment are greatly reduced, or often entirely removed when a cancer has metastasized.

Browse All Tags